Modimelanotide (INN) (code names AP-214, ABT-719, ZP-1480) is a melanocortinergic peptide drug derived from α-melanocyte-stimulating hormone (α-MSH) which... 6 KB (304 words) - 12:45, 13 May 2023 |
Pharmaceuticals and bremelanotide by Palatin Technologies. Others include modimelanotide and setmelanotide. Afamelanotide (brand name Scenesse) has been approved... 10 KB (940 words) - 05:25, 31 October 2023 |
 | the same family as bremelanotide include afamelanotide (NDP-α-MSH), modimelanotide, and setmelanotide. Studies in the early 1960s showed that administration... 25 KB (2,118 words) - 16:47, 8 December 2023 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 17 KB (1,300 words) - 08:48, 5 August 2023 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 16 KB (1,705 words) - 14:42, 13 May 2024 |
 | peptide full agonist Melanotan II - nonselective peptide full agonist Modimelanotide - nonselective peptide full agonist Setmelanotide - nonselective peptide... 33 KB (3,769 words) - 04:57, 6 May 2024 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 27 KB (3,312 words) - 02:13, 8 March 2024 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 24 KB (2,774 words) - 05:13, 31 October 2023 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 25 KB (1,891 words) - 06:11, 26 April 2024 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 18 KB (1,407 words) - 04:49, 3 March 2024 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 5 KB (379 words) - 09:51, 23 March 2024 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 14 KB (1,278 words) - 13:21, 23 January 2024 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 28 KB (2,388 words) - 12:23, 24 January 2024 |
Non-selective α-MSH β-MSH γ-MSH Afamelanotide Bremelanotide Melanotan II Modimelanotide Setmelanotide MC1-selective BMS-470,539 MC4-selective PF-00446687 PL-6983... 10 KB (1,143 words) - 18:46, 8 November 2023 |
I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 8 KB (456 words) - 09:21, 24 July 2023 |
I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 12 KB (1,639 words) - 01:40, 18 December 2023 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 4 KB (320 words) - 07:46, 7 August 2023 |
 | obesity. α-MSH β-MSH γ-MSH ACTH Afamelanotide Bremelanotide Melanotan II Modimelanotide Setmelanotide was approved by FDA as first-ever therapy for chronic... 33 KB (3,164 words) - 08:06, 10 March 2024 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 5 KB (192 words) - 19:46, 2 July 2022 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 4 KB (199 words) - 04:19, 25 March 2024 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 5 KB (496 words) - 04:14, 25 March 2024 |
I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 1 KB (92 words) - 17:17, 18 April 2020 |
| I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 12 KB (1,469 words) - 01:18, 27 December 2023 |
I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 5 KB (297 words) - 10:55, 29 December 2023 |
 | favorable pharmacodynamic profile. Afamelanotide Bremelanotide Melanotan II Modimelanotide Setmelanotide Kang L, McIntyre KW, Gillooly KM, et al. (October 2006)... 4 KB (243 words) - 01:22, 26 April 2022 |
 | I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 20 KB (2,316 words) - 22:00, 18 March 2024 |
I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 5 KB (261 words) - 01:44, 28 August 2023 |
| I) BMS-470539 Bremelanotide HS-014 HS-024 MSH (α, β, γ) Melanotan II Modimelanotide PL-8177 SHU-8914 SHU-9005 SHU-9119 SNAP-7941 Antagonists: ASIP MC2 Agonists:... 14 KB (1,510 words) - 01:18, 27 December 2023 |